This idea has some basis given the variability of the clinical phenotypes linked to NRXN1 deletions, which include autism, schizophrenia, mental retardation, and speech delay (Ching et al., 2010), with patient populations that have mixed genetic backgrounds compared with repeatedly backcrossed mouse strains. This evidence concerns the gene NRXN1 and schizophrenia.